Search

everythinglearnresearchcommunity

for

Search:↓

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

The man's diarrhea was caused by a rare disorder called Cronkhite-Canada syndrome, which improved with specific medications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Amyloid deposits linked to a type of protein may cause a unique pattern of hair loss by disrupting hair growth cycles.

Low PON1 levels may indicate and predict the severity of hair loss.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Targeted cancer therapies often cause serious skin problems that need careful management.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Cetuximab can cause excessive eyelash growth.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.